# Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer

Source: https://onco.cc/trials/nct04801511/  
OnCo record `nct04801511` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of High-dose intravenous vitamin C in Rectal cancer, run by Zhou Fuxiang, with a status the registry has not verified recently.

## Summary

Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer is a phase 2 interventional study registered as NCT04801511 by Zhou Fuxiang, with 60 participants planned, started 2021-03-08 and due to reach its primary completion in 2023-06-30. Interventions recorded: Vitamin C. Conditions recorded: Rectal Cancer.

Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04801511
- Phase: 2
- Setting: Safety and Efficacy of Preoperative IMRT (Intensity-modulated Radiation Therapy) With Concurrent High-dose Intravenous Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer Patients: a Prospective Study.
- Sponsor: Zhou Fuxiang
- Enrolled: 60

## Sources

- ClinicalTrials.gov NCT04801511: https://clinicaltrials.gov/study/NCT04801511

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [High-dose intravenous vitamin C](https://onco.cc/technologies/high-dose-vitamin-c/)

---
JSON: https://onco.cc/api/v1/entities/nct04801511.json